Updated:
Amalgam RX
Amalgam RX is a family office in Wilmington, Delaware, investing across healthcare services, private credit, and real estate.
Amalgam RX
Amalgam RX is a family office founded in an undisclosed year, headquartered in Wilmington, Delaware. The firm's name and location suggest ties to the healthcare or pharmaceutical sectors, though the originating family or wealth source has not been publicly identified. Public records do not name any principals or operating leads. The firm's investment strategy appears to span healthcare services, private credit, and real estate — a mix typical of family offices seeking stable, yield-oriented returns. There are no confirmed portfolio companies, deals, or co-investors in public records. Geographic focus is likely domestic, centered on the United States. Amalgam RX does not publicly disclose AUM, team size, or additional offices. No affiliated philanthropic vehicles or operating companies have been identified. The firm has no notable recent operational events in the public domain. A genuine structural differentiator is unclear from available data. The firm's choice of Delaware as a domicile is common for family offices seeking favorable corporate and trust law, but no governance or succession details are on the record.
General information
Firm type
Single Family Office
Year founded
—
AUM
Undisclosed
Location
Region
North America
Country
United States
City
Wilmington
Corporate office
Wilmington, Delaware, United States
Sector focus
Frequently asked questions
Who runs investment decisions at Amalgam RX?
No principals or investment committee members are publicly named for Amalgam RX. The firm's decision-making structure is not disclosed in public records.
What sectors does Amalgam RX focus on?
Based on the firm's profile, Amalgam RX targets healthcare services, private credit, and real estate. This mix suggests a preference for income-generating and lower-volatility assets.
Is Amalgam RX a single family office or multi-family office?
Public records indicate Amalgam RX operates as a single family office, likely managing the wealth of a single family or individual. No multi-family service offerings are documented.
Does Amalgam RX participate in direct deals or fund commitments?
The firm's investment approach is not publicly detailed. Given its focus on private credit and real estate, it may engage in both direct investments and fund vehicles, but no specific deals are on record.
Where does the underlying wealth come from?
The origin of wealth for Amalgam RX is not publicly disclosed. The firm's name may imply a healthcare or pharmaceutical connection, but this is speculative.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on family offices?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: